Hanson Wade Group

🎟️Experience the 𝗖𝗲𝗹𝗹 & 𝗚𝗲𝗻𝗲 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗔𝗳𝗳𝗮𝗶𝗿𝘀 𝗦𝘂𝗺𝗺𝗶𝘁—an unmissable 𝟯-𝗱𝗮𝘆 𝗺𝗲𝗲𝘁𝗶𝗻𝗴 with a standout 𝘄𝗼𝗿𝗸𝘀𝗵𝗼𝗽 𝗱𝗮𝘆 dedicated to mastering global regulatory affairs and IND submissions in cell and gene therapy.    𝗦𝗲𝗲 𝗪𝗼𝗿𝗸𝘀𝗵𝗼𝗽 𝗗𝗲𝘁𝗮𝗶𝗹𝘀 𝗶𝗻 𝘁𝗵𝗲 𝗙𝘂𝗹𝗹 𝗕𝗿𝗼𝗰𝗵𝘂𝗿𝗲 - https://ter.li/hkqklb   🌍In the competitive field of cell and gene therapies, where global expansion is key, our carefully crafted workshops are here to 𝘀𝗶𝗺𝗽𝗹𝗶𝗳𝘆 𝘆𝗼𝘂𝗿 𝗰𝗼𝗺𝗺𝗲𝗿𝗰𝗶𝗮𝗹𝗶𝘇𝗮𝘁𝗶𝗼𝗻 𝗽𝗿𝗼𝗰𝗲𝘀𝘀 and help you 𝗼𝘃𝗲𝗿𝗰𝗼𝗺𝗲 𝗸𝗲𝘆 𝗰𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗲𝘀.   Discover how our comprehensive topics address your challenges in the 𝗙𝘂𝗹𝗹 𝗕𝗿𝗼𝗰𝗵𝘂𝗿𝗲 - https://ter.li/hkqklb   This is your opportunity to join regulatory experts and 𝟮𝟬+ 𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝘀𝗽𝗲𝗮𝗸𝗲𝗿𝘀 for 𝟯 𝗳𝘂𝗹𝗹 𝗱𝗮𝘆𝘀 of insights and networking.   #CellAndGeneTherapyRegulatoryAffairsSummit

📢 Calling all EHS professionals    Join expert speakers from companies such as Eli Lilly and Company, Gilead Sciences, Takeda and more to work towards eliminating risk & ensuring compliance in biopharmaceutical R&D & manufacturing sites at the EHS&S for Biopharma & Pharma Summit West.    Download their full sessions details here ➡️ https://ter.li/87xhko

Don’t miss out on your chance to 𝐬𝐚𝐯𝐞 𝐮𝐩 𝐭𝐨 $𝟓𝟓𝟎 on your ticket for the highly anticipated 𝐑𝐚𝐰 𝐌𝐚𝐭𝐞𝐫𝐢𝐚𝐥𝐬 𝐟𝐨𝐫 𝐂𝐞𝐥𝐥 & 𝐆𝐞𝐧𝐞 𝐓𝐡𝐞𝐫𝐚𝐩𝐲 𝐒𝐮𝐦𝐦𝐢𝐭.   Register here ➡️ https://ter.li/sjvl4g

🎯Give yourself the best shot at commercializing new therapies with the 𝗖𝗲𝗹𝗹 & 𝗚𝗲𝗻𝗲 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗔𝗳𝗳𝗮𝗶𝗿𝘀 𝗦𝘂𝗺𝗺𝗶𝘁—your ultimate resource for mastering end-to-end communication strategies.   𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝘁𝗵𝗲 𝗙𝘂𝗹𝗹 𝗔𝗴𝗲𝗻𝗱𝗮 𝗛𝗲𝗿𝗲 - https://ter.li/gzje4c   𝗪𝗵𝗮𝘁 𝗬𝗼𝘂'𝗹𝗹 𝗚𝗮𝗶𝗻: This event is laser-focused on optimizing medical affairs within the cell & gene therapy sector. With never-before-seen sessions and a 𝘀𝗽𝗲𝗰𝗶𝗮𝗹 𝗳𝗼𝗰𝘂𝘀 𝗼𝗻 𝗽𝗮𝘆𝗼𝗿 𝗲𝗻𝗴𝗮𝗴𝗲𝗺𝗲𝗻𝘁, you'll gain insights to 𝘀𝗲𝗰𝘂𝗿𝗲 𝘃𝗶𝘁𝗮𝗹 𝗶𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁𝘀 for high-cost therapies.   𝗔𝗰𝘁 𝗡𝗼𝘄! This is a once-a-year opportunity, and tickets are selling out fast. Don't let it pass by.   📄 𝗟𝗲𝗮𝗿𝗻 𝗠𝗼𝗿𝗲 𝗶𝗻 𝘁𝗵𝗲 𝗙𝘂𝗹𝗹 𝗔𝗴𝗲𝗻𝗱𝗮 - https://ter.li/gzje4c   #CellAndGeneTherapyMedicalAffairsSummit

The 𝗖𝗼𝗺𝗽𝗹𝗲𝘅 𝗕𝗶𝗼𝗲𝗻𝗴𝗶𝗻𝗲𝗲𝗿𝗶𝗻𝗴 𝗳𝗼𝗿 𝗖𝗲𝗹𝗹 𝗧𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 𝗦𝘂𝗺𝗺𝗶𝘁 is your chance to tackle core challenges like safety, persistence, and payload delivery in next-gen treatments for solid tumors!   𝗟𝗲𝗮𝗿𝗻 𝗺𝗼𝗿𝗲 𝗶𝗻 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗽𝗿𝗼𝗴𝗿𝗮𝗺 - https://ter.li/krkwrz   𝗪𝗵𝗮𝘁'𝘀 𝗶𝗻 𝘀𝘁𝗼𝗿𝗲: • Connect with leading molecular biologists to explore collaborations and innovative approaches • Discuss logic-gated therapies, payload capacity, and delivery techniques to shape the future of cell therapy • Focus on the latest in safety and persistence improvements for more effective treatments   ⏳This Friday is your 𝗹𝗮𝘀𝘁 𝗰𝗵𝗮𝗻𝗰𝗲 to 𝘀𝗮𝘃𝗲 𝘂𝗽 𝘁𝗼 $𝟳𝟬𝟬 on your pass! 𝗦𝗲𝗲 𝗱𝗶𝘀𝗰𝗼𝘂𝗻𝘁𝘀 𝗶𝗻 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗮𝗴𝗲𝗻𝗱𝗮 - https://ter.li/krkwrz   𝘛𝘩𝘪𝘴 𝘪𝘴 𝘰𝘶𝘳 𝙗𝙞𝙜𝙜𝙚𝙨𝙩 𝙙𝙞𝙨𝙘𝙤𝙪𝙣𝙩, a𝘢𝘯𝘥 𝘱𝘳𝘪𝘤𝘦𝘴 𝘸𝘪𝘭𝘭 𝘰𝘯𝘭𝘺 𝘳𝘪𝘴𝘦 𝘧𝘳𝘰𝘮 𝘩𝘦𝘳𝘦. 𝙈𝙞𝙨𝙨 𝙩𝙝𝙞𝙨, 𝘢𝘯𝘥 𝘺𝘰𝘶'𝘭𝘭 𝙢𝙞𝙨𝙨 𝙤𝙪𝙩.   #ComplexBioengineeringforCellTherapiesSummit

Join presidents, chiefs, principal scientists, and professors at the 𝟲𝘁𝗵 𝗠𝗮𝗰𝗿𝗼𝗽𝗵𝗮𝗴𝗲-𝗗𝗶𝗿𝗲𝗰𝘁𝗲𝗱 𝗧𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀 𝗦𝘂𝗺𝗺𝗶𝘁 for crucial discussions on the 𝗹𝗮𝘁𝗲𝘀𝘁 𝗶𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁 𝘁𝗿𝗲𝗻𝗱𝘀 and treatments for oncology, autoimmunity, inflammation, and beyond.   Curious who's attending? See the 𝗦𝗻𝗮𝗽𝘀𝗵𝗼𝘁 𝗼𝗳 𝗔𝘁𝘁𝗲𝗻𝗱𝗲𝗲𝘀 𝗛𝗲𝗿𝗲 - https://ter.li/2se3vd   𝗗𝗼𝗻'𝘁 𝗺𝗶𝘀𝘀 𝘁𝗵𝗶𝘀 𝗼𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝘆 𝘁𝗼: 💡Gain insights into the latest macrophage-therapeutics data and targets 💡Discover new applications beyond oncology, including autoimmunity and neurodegenerative diseases 💡Explore CAR-M therapy advancements   Join 𝟯 𝗶𝗻𝘁𝗲𝗿𝗮𝗰𝘁𝗶𝘃𝗲 𝘄𝗼𝗿𝗸𝘀𝗵𝗼𝗽𝘀, 𝟴+ 𝗵𝗼𝘂𝗿𝘀 𝗼𝗳 𝗻𝗲𝘁𝘄𝗼𝗿𝗸𝗶𝗻𝗴, and 𝟮𝟱+ 𝗳𝗼𝗰𝘂𝘀𝗲𝗱 𝘀𝗲𝘀𝘀𝗶𝗼𝗻𝘀 on macrophage therapeutics. 𝗟𝗲𝗮𝗿𝗻 𝗺𝗼𝗿𝗲 𝗶𝗻 𝘁𝗵𝗲 𝗙𝘂𝗹𝗹 𝗔𝗴𝗲𝗻𝗱𝗮 - https://ter.li/ekle4x #MacrophageDirectedTherapiesSummit

We’re excited to announce that The Antibody Society has joined us as a media partner for the CDD for Biologics Summit! As a leading international non-profit organization, the Antibody Society is at the forefront of antibody research and development. They offer cutting-edge information, facilitate industry-leading conferences, and uphold high standards in scientific communication. Find out more about the Antibody Society and other key players participating in the CDD for Biologics Summit by downloading the event guide here: https://ter.li/2vgzwb Join us to explore cutting-edge innovations, automate and streamline data collection, integrate experimental insights, and harness deep learning models to advance complex biologics pipelines! Secure your seat: https://ter.li/tg59ow #AntibodyResearch #AISummit #ComputationalBiology #MachineLearning

⏰ Time's Almost Up! ⏰ The Early Bird pricing for the 12th IMPACCT Real World Evidence Summit ends THIS FRIDAY! Why Attend? ✔ Case-study-based insights on leveraging tokenization to enhance RWD quality with Otsuka Pharmaceutical Companies (U.S.) ✔ Proven strategies to generate integrated evidence plans to reduce market access uncertainty and achieve regulatory grade submissions with Takeda ✔ Navigating the uncertainty brought by generative AI and NLP to optimize RWD interpretation with Chiesi Group ✔ Implementing effective chart review data to reduce data inefficiencies with Bayer Secure your spot today and join 140+ industry pioneers including Johnson & Johnson, Pfizer, Eli Lilly and Company, Sanofi, and more. Together, let's forge a comprehensive evidence plan, break free from silos, and bridge the gap between clinical research and practice. Find out more here: https://ter.li/wtyt0v 

With only limited passes remaining, time is running out to register for the 5th Gene Therapy for Ophthalmic Disorders Summit! 📢 We are excited that companies like Apellis Pharmaceuticals, Iveric Bio, An Astellas Company, Nanoscope Therapeutics Inc., REGENXBIO Inc., Adverum Biotechnologies, and more, are sharing exclusive case studies to help you harness genetic medicine for treatment of rare and common eye diseases. Register now to secure your place and unite with 50+ experts: https://ter.li/1bnel3  Or view the full event guide for the presentation details: https://ter.li/jpghof

Exclusive discounted tickets to the Patient Recruitment for Rare Disease Trials Summit are expiring today at midnight 📢 View the agenda to see the full speaker faculty and presentation details you can’t afford to miss: https://ter.li/oxulbb Confirmed companies already in the room include Sanofi, Biogen, Astellas Pharma, Moderna, BioMarin Pharmaceutical Inc., PepGen, BridgeBio, Novo Nordisk, Day One Biopharmaceuticals and Reata Pharmaceuticals, Inc. With so many companies already involved, don’t miss this opportunity to be part of the conversation and make a tangible impact on rare disease research! Register your place today to save up to $1100: https://ter.li/3w7e2a #RareDisease #HealthcareAdvocacy #PatientCare #PatientAdvocacy #PatientRecruitment #RareDiseases #PatientAdvocate #PatientCentricity #PatientExperience #Clinicaltrials #Clinicaltrialrecruitment